Bristol Myers Squibb & Co (NYSE:BMY) on Tuesday released topline results from the Phase 3 ARISE trial evaluating the efficacy and safety of Cobenfy (xanomeline and trospium chloride) as an ...

A phase 3 trial in metastatic melanoma is ongoing, with a Biologics License Application expected by year-end. The vaccines offer a novel approach by targeting the entire tumor environment ...

Solid State Logic continues to expand its powerful lineup of plug-ins and software for its SSL 360° platform, this time ...

Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA potentially in ...

A tragic aviation incident occurred in Boca Raton, Florida, on Friday morning, as a small aircraft went down shortly after takeoff, resulting in the deaths of all three individuals on board ...

Sanofi is banking on the totality of data from the three phase 3 trials supporting potential filings for tolebrutinib, with the HERCULES result backed up by secondary endpoint data from the GEMINI ...

Data from the two phase 3 studies also showed that clinical decline was reduced in participants who had plasma p-tau181 reduction at 78 weeks, which Haeberlein said was a "meaningful" finding.

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial ...